Feb 14, 2020
Delbert G. Robinson, M.D., joins Dr. Dixon and Dr. Berezin to discuss barriers to the use of long-acting injectable (LAI) antipsychotic medication.
- Dr. Robinson's path to this particular area of research [1:43]
- How have people traditionally viewed LAIs? [3:32]
- A different approach to LAIs [4:13]
- The trend to use qualitative methods to understand perspectives of different stakeholders [7:28]
- Scope of the study [8:13]
- What the barriers are to more uptake of the use of LAIs [14:18]
- Barriers stemming from the individual level (interactions between a clinician and a patient) and the systems level (clinics not having appropriate infrastructure) [19:48]
- What is the next step in this line of research? [22:20]
Subscribe to the podcast here.
Check out Editor's Choice, a set of curated collections from the rich resource of articles published in the journal. Sign up to receive notification of new Editor's Choice collections.
Browse other articles on our web site.
Be sure to let your colleagues know about the podcast, and please rate and review it wherever you listen to it.
Listen to other podcasts produced by the American Psychiatric Association.
Follow the journal on Twitter.
E-mail us at psjournal@psych.org